Your browser doesn't support javascript.
loading
A portable droplet microfluidic device for cortisol measurements using a competitive heterogeneous assay.
Evans, Gareth W H; Bhuiyan, Wahida T; Pang, Susan; Warren, Brett; Makris, Kyriacos; Coleman, Sharon; Hassan, Sammer-Ul; Niu, Xize.
Afiliação
  • Evans GWH; Mechanical Engineering, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton, SO17 1BJ, UK. x.niu@soton.ac.uk and Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.
  • Bhuiyan WT; Mechanical Engineering, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton, SO17 1BJ, UK. x.niu@soton.ac.uk.
  • Pang S; National Measurement Laboratory (LGC), Queens Road, Teddington, TW11 0LY, UK.
  • Warren B; SouthWestSensor Ltd, 2 Venture Road, Chilworth, Southampton, SO16 7NP, England, UK.
  • Makris K; SouthWestSensor Ltd, 2 Venture Road, Chilworth, Southampton, SO16 7NP, England, UK.
  • Coleman S; SouthWestSensor Ltd, 2 Venture Road, Chilworth, Southampton, SO16 7NP, England, UK.
  • Hassan SU; Mechanical Engineering, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton, SO17 1BJ, UK. x.niu@soton.ac.uk.
  • Niu X; Mechanical Engineering, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton, SO17 1BJ, UK. x.niu@soton.ac.uk and Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK and SouthWestSensor Ltd, 2 Venture Road, Chilworth, Southampton, SO16 7N
Analyst ; 146(14): 4535-4544, 2021 Jul 12.
Article em En | MEDLINE | ID: mdl-34137757
ABSTRACT
Point-of-care monitoring of chemical biomarkers in real-time holds great potential in rapid disease diagnostics and precision medicine. However, monitoring is still rare in practice, as the measurement of biomarkers often requires time consuming and labour intensive assay procedures such as enzyme linked immunosorbent assay (ELISA), which pose a challenge to an autonomous point-of-care device. This paper describes a prototype device capable of performing ELISA autonomously and repeatedly in a high frequency using droplet microfluidics. Driven by a specially designed peristaltic pump, the device can collect liquid samples from a reservoir, produce trains of droplets, complete magnetic bead based ELISA protocols and provide readouts with colourimetric measurement. Here, cortisol was chosen as a target analyte as its concentration in the human body varies on a circadian rhythm which may be perturbed by disease. The prototype device draws in and analyses 350 nL of the sample containing free bioactive cortisol every 10 seconds, with a sample-to-signal time of 10 minutes, and measures favourably in the analytical range of 3.175-100 ng ml-1, with reliably lower variability compared with the well plate based assay. As most ELISA type assays share similar procedures, we envisage that this approach could form a platform technology for measurement or even continuous monitoring of biomarkers in biological fluids at the point-of-care.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Microfluídica / Dispositivos Lab-On-A-Chip Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Analyst Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Microfluídica / Dispositivos Lab-On-A-Chip Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Analyst Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido